### Medtrum's New Patch Pump Artificial Pancreas System Medtrum, a company based in China, is developing a new closed-loop system called the A6 TouchCare. This system includes a disposable patch pump and a continuous glucose monitor (CGM). The A6 TouchCare system is expected to be available outside the U.S. by the end of this year and could be the first artificial pancreas system without any tubing. #### Key Features - **A6 TouchCare System**: This is the main system that integrates the patch pump and CGM. - **P6 EasyPatch Disposable Patch Pump**: A disposable pump that delivers insulin without the need for tubing. - **S6 EasySense CGM**: A continuous glucose monitor that tracks blood sugar levels. #### Benefits - **No Tubing**: The system is tubeless, making it more convenient and less cumbersome for users. - **Cost-Effective**: The CGM component is expected to be 40% less expensive than current market leaders like Dexcom. - **Accessibility**: Lower costs could make CGM more accessible, especially in places like the UK where government funding is limited. #### Challenges - **Manual Glucose Entry**: The current system requires manual entry of glucose levels, which could be a downside for some users. - **Regulatory Approval**: While the system has CE Mark approval in Europe, it is still awaiting FDA approval in the U.S. #### Market Impact If Medtrum's pricing is competitive, it could disrupt the current market by making advanced diabetes care more affordable and accessible. This could lead to higher adoption rates for insulin pumps and CGMs, improving the quality of life for many people with diabetes. Stay tuned for more updates as Medtrum moves closer to launching this innovative system.